mass lesions stemming from salivary glands are still continuing. [4, 5] In many studies, degrees of sensitivity and specificity of FNAB have been reported. Generally speaking, degrees of its sensitivity and specificity vary between 85-99% and 96-100%, respectively. [5, 6] In the present study, factors affecting the diagnostic value and worth of FNAB used in the diagnosis of parotid tumors have been analyzed.
Materials and Methods
In this study, 84 patients who had been operated for a parotid mass lesion between the years 2005 and 2011 in 1st ENT Clinics of Ankara Numune Training and Research Hospital were retrospectively analyzed and 76 patients who had undergone preoperative FNAB with available data were included in the study.
Data of all patients about preoperative radiological and cytological analyses, surgical techniques used, postoperative histopathologic diagnoses, complications and followup were retrieved and evaluated. This study was conducted in accordance with the decree of the Local Ethics Committee and after obtaining enlightened consent forms from all patients.
The impact of FNABs performed with or without the aid of ultrasound (US) guidance on adequacy and diagnostic value of aspirates collected by FNABs, structure of tumors delineated by US (solid, cystic or mixed), rates of diagnostic changes caused by FANB, its discriminative capability in differentiating between malignant and benign tumors and its success in the establishment of tumor-specific diagnosis and also the effect of dimensions and locations of parotid masses on diagnostic value of FNAB results were analyzed. Finally interrelationship between FNAB results and these retrieved data and also its preoperative significance on the choice of the surgical alternative were investigated.
All statistical analyses were realized using SPSS 10.0 statistical software package (SPSS Inc. Chicago, IL, USA). A p value of 0.005 was considered to be statistically significant.
Results
Preoperative ultrasonographic examinations performed on the patients with parotid masses included in the study detected parotid tumors with diameters of 0-2 cm (19.7%; 15/76), 2-4 cm (52.6%; 40/76) and ≥4 cm (27.6%; 21/76) with rates indicated within parentheses. Parotid tumors were seen in the superficial (73.7%; 56/76) or deep (14.5%; 11/76) parotid lobes or both (11.8%; 9/76). Ultrasonographic examinations detected solid, cystic or mixed tumors in 68.4 % (52/76), 7.9 % (6/76) and 23.7 % (18/76) of the patients respectively.
During preoperative period, FNABs were performed under polyclinic conditions with or without the guidance of US in 52.6% (40/76) and 47.4% (36/76) of the patients, respectively. FNAB results also revealed benign (75%; 57/76) and malignant tumors (10.5%, 8/76) and 14.5% (11/76) of them were non-diagnostic: postoperative histopathological results were reported as benign (81.6%; 62/76) or malignant (18.4%; 14/76) tumors. Results of histopathologic examinations of parotid gland specimens are indicated in Table 1 .
Concordance between the results of FNAB and postoperative histopathological examinations (i.e. discriminative capability of FNAB in differentiating between benign and malignant masses): Comparison of the concordance of the results of preoperative FNAB cytologies and postoperative histopathologic examinations as for discriminative capability in differentiating between malignant and benign masses is shown in Table 2 . A certain percentage (27.3%; 3/11) of non-diagnostic tumors as evaluated by FNAB was found to be malignant mass lesions after histopathologic examinations. Majority of malignant (87.5%; 7/8) and benign (93%; 53/57) tumors determined based on FNAB results were also confirmed by histopathological examinations. A statistically significant correlation was found between preoperative FNAB and postoperative histopathology results in discrimination between benign and malignant tumors (p<0.001). Sensitivity and specificity of FNAB results
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Kaygusuz U et al. are given in Table 3 . Eight non-diagnostic tumors assessed based on FNAB results were revealed to be three pleomorphic adenomas (PAs), two cases of Warthin's tumor (WT), two lymphoid hyperplasias and one basal cell adenoma (BCA) after their histopathological examinations. Only one case of malignancy based on FNAB results was reported as PA after histopathological examination. Histopathologically reported malignant tumors classified as benign neoplasms according to FNAB results were noted by us to be acinic cell carcinoma (ACC), malign lymphoma, papillary cystic salivary gland tumor and myoepithelial carcinoma ex-PA.
Evaluation of the factors affecting cytopathological concordance in tumors whose FNAB results and postoperative histopathologic diagnoses matched completely: In patients whose histopathologic diagnoses could be firmly established during examination of preoperatively obtained FNAB specimens, complete cytopathological concordance with FNAB results was analyzed. Nearly all of the cases demonstrating complete cytopathological concordance consisted of benign tumors, while in only one of the malignant tumors, diagnosis of malignant melanoma could be made with certainty by the examination of FNAB specimens. Thirty-one parotid neoplasms (evaluated as benign tumors based on FNAB results) demonstrated complete cytopathological concordance were diagnosed as PA (n=20), WT (n=8), lipoma (n=2) and reactive lymphoid hyperplasia (n=1). In 42.1% of all patients whose FNAB results and postoperative histopathology reports were completely alike, establishment of accurate and precise diagnosis by examination of FNAB specimens was highly probable for benign tumors relative to malignant ones. The relationship between tumors with similar FNAB and postoperative histopathological results (complete cytopathological concordance) and their anatomical structure (solid, cystic or mixed) is given in Table 4 . A significant correlation could not be found between tumoral characteristics on one hand and complete concordance between FNAB and cytopathologic results on the other side (p=0.358). Complete cytopathological concordance was evaluated with respect to the application method of the FNAB procedure (with or without US guidance) and tumoral structure (benign or malign), and distribution of the values of complete concordance between FNAB and cytopathological results are given in Table 5 . In US-guided FNABs, complete cytopathological concordance was achieved in 37.5% (9/24) of solid, 25% (1/4) of cystic and 50% (6/12) of mixed tumors, while FNABs performed without the aid of US demonstrated complete cytopathological concordance in 46% (13/28) of solid and 50% (3/6) of mixed tumors. Complete cytopathological concordance was not observed in none of the cystic tumors. Even though US-guidance increases diagnostic value of FNAB in cystic tumors, complete concordance between FNAB and cytopathological results was not statistically significantly influenced whether FNAB is performed under US guidance or not (p1=0.626, p2=0.423). parotid tumors was done, and any statistically significant correlation between them was not detected (p=0.580) ( Table 6 ).
Comparison of tumoral location, FNAB results and postoperative complete histopathologic concordance:
Comparative data about location of the tumor, FNAB results and complete postoperative histopathologic concordance are given in Table 7 . Comparison of tumoral location and cytopathologic concordance was analyzed and complete cytopathologic concordance was seen in cases with superficial (46.4%; 26/56), deep (27.3%; 3/11) and both superficial and deep thyroid lobe tumors (33.3%; 3/9). A statistically significant correlation could not be found between location of the tumor and complete cytopathologic concordance (p=0.426). Complete concordance between the results of US-guided FNAB and postoperative histopathologic examinations with respect to location of the tumor (complete cytopathologic concordance) was detected in 41.4% (12/29) of superficial, in 40.0% (2/5) of deep and in 33.3% (2/6) of both superficial and deeply located tumors. The corresponding rates for FNABs performed without US guidance were found to be 51.9% (14/27), 16.7% (1/6) and 33.3% (1/3), respectively. Results of FNABs performed with or without US-guidance (p2) did not demonstrate statistically significant differences as for location of the tumor (p1). (p1=0.426, p2=0.935).
Comparison of tumoral characteristics, use of US guidance and adequacy (or inadequacy) (diagnosticnon-diagnostic) of the FNAB specimen for histopathologic examination: Solid, cystic and mixed structure of the tumors of 40 (52.6%) patients who had undergone USguided FNAB and diagnostic value of FNAB material were shown in Table 8 . Implementation of US increases diagnostic value of FNAB. Especially in mixed tumors, diagnostic value of US-guided FNABs was found to be statistically significantly higher than those applied without the aid of US (p=0.003).
Histopathologic results of 11 (14.5%) patients with non-diagnostic FNAB obtained in our study were given in Table 9 .
Discussion
The most important problem encountered in the diagnosis of parotid tumors lies in the certainty of our predictive diagnosis made by available imaging modalities and examination techniques. Indeed, preemptive recognition of the nature of the mass lesion (benign or malign) beforehand will enable us to give sufficient preoperative information to the patient about his/her disease. The potential risk of malignancy if the patient declines surgical intervention, progression of the disease, feasibility of complete eradication of the disease, knowledge of non-surgical alternatives are very important issues both for the patient and the physician. On the other hand, potential complications of the parotid surgery and surgical morbidity are not easily acceptable and accountable phenomena both for the patient and the surgeon in cases where the physician has no idea about the diagnosis.
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FNAB is a sensitive technique used widely in the salivary gland tumors with proven value. Especially preoperative recognition of the lesion and planning the appropriate treatment are very important and useful procedures. FNAB can discriminate between patients requiring a small-scale or more extensive, radical surgery. Besides, it can determine salivary gland diseases amenable to non-surgical therapy. Thus, the patient will not expose to unnecessary morbidities. Besides, the patient will not be exposed to morbidities, and harmful effects of inadequate cure, use of unnecessary diagnostic and therapeutic procedures, In addition, problems such as loss of limited financial resources and waste of time will be obviated. Debates about use of FNAB in the diagnosis of masses originating from salivary glands are continuing for years. [4, 5] In one of the first FNAB series of 288 cases published by Spiro et al. in 1975 , the authors disregarded the significance of FNAB because of its misleading outcomes and emphasized that a parotid mass which does not decrease in size or gradually becomes larger is a candidate for surgical treatment. Therefore, they concluded that FNAB was not an indispensable diagnostic tool for the decision-making process for surgery. [7] FNAB results of 160 salivary gland tumors were published in 1990 by Shaha et al. and 84 of them were related to parotid tumors. The authors indicated rates of diagnostic accuracy over 90% and emphasized the inadequacy of FNAB in discriminating chronic inflammatory conditions as sialaadenitis from stasis. [8] In a series of 187 cases with salivary gland FNAB data published by Nettle et al. in 1989, the authors indicated that FNAB could specifically diagnose benign tumors more accurately, while FNAB was useful in differentiating malignant parotid tumors from benign lesions and inflammatory diseases of the parotid gland. [9] All of our 76 patients operated for parotid tumors had undergone preoperative FNAB procedures. FNAB is an indispensable procedure for the investigation of head and neck masses including salivary gland masses detected in our and many ENT-Head and Neck Surgery clinics worldwide. FNAB can be performed using 22-25 gauge needles under polyclinic conditions and US-guidance. To increase diagnostic accuracy of FNAB, adequate amount of tissue suitable for cytologic examination should be aspirated using FNAB needles. Because of hypervascularity of head and neck region, aspirates are contaminated by blood components which in turn complicate establishment of diagnosis by FNAB. Use of large bore needles traumatizes vascular structure, with resultant contamination of aspirate by blood components. This complication decreases diagnostic adequacy of FNAB and damages tumoral tissue, which might Table 8 . Solid, cystic and mixed structure of the tumors of patients who had undergone US-guided fine-needle aspiration biopsy and diagnostic value of fine-needle aspiration biopsy material.
Histopathological diagnosis n
Warthin's tumor 3
Pleomorphic adenoma 2
Basal cell adenoma 2
Squamous cell carcinoma 1
Reactive lymphoid hyperplasia 2
Adenocystic carcinoma 1 Table 9 . Histopathologic results of patients with non-diagnostic fineneedle aspiration biopsy.
falsify postoperative histopathologic diagnosis of the tumor. With use of small-bore needle tips, sufficient amount of aspirate can not be retrieved which decrease diagnostic value of FANB. This issue and suspected seeding of tumoral components in salivary gland tumors are frequently expressed by investigators who argued against routine use of FANB in salivary gland tumors. [5] Mukunyadzi et al. analyzed 94 salivary gland specimens as for the presence of infarction, bleeding, tumoral seeding along the entry route of the needle and fibrosis and reported that 25-gauge needles are safe and histological alterations induced by FNAB procedure did not complicate establishment of diagnosis in none of the cases. [10] Histopathology reports of the patients operated by us did not indicate the presence of any histological alterations caused by FNAB, which complicated establishment of diagnosis.
In their large-scale studies, many authors have revealed FNAB as a proper diagnostic tool. In most of these series diagnostic accuracy rates climbed to 95 percent. Its sensitivity and specificity in the detection of benign tumors were found to be 88-98% and at least 94%, respectively. Its accuracy rate in the diagnosis of especially PA is over 90 percent. [5] FNAB can not yield very accurate results in the discrimination among many malignant tumors. Indeed, in our study, sensitivity and specificity of FNAB were found to be 63%, and 98%, respectively. Postoperative histopathology reports preoperative FNAB results of 53 out of 54 patients with benign postoperative histopathology results were also reported as benign. Also in our study, diagnostic performance of FNAB appears to be very successful in the detection of benign tumors.
Some publications have asserted that US-guided FNAB facilitated retrieval of biopsy material from non-palpable or heterogenous tumors. [11] We performed US-guided FNABs in 52.6% of our patients, while 47.4% of the biopsies were performed without the aid of US, under polyclinic conditions. In 92.5% of the US-guided FNABs adequate material can be obtained for cytologic examination, while only 77.8% of the FNABs performed without the aid of US could yield adequate material. Though biopsy material retrieval rates between two groups are not very different, US-guidance especially facilitates easy access into nonpalpable masses.
Fine-needle aspiration biopsy is a very effective technique in discriminating between malignant and benign salivary gland tumors, but it is not comparatively effective in establishing precise histopathological diagnosis. In many studies, FNAB had a tumor-specific diagnostic value ranging between 25-and 85 percent. [4] Preoperatively, establishment of tumor-specific diagnosis using FNAB is termed as complete cytopathologic concordance (tumor-specific diagnosis). In a study performed in Turkey by Mahmudova et al. in 2010, the rate of complete cytopathologic concordance was reported as 29 percent. [12] In a study conducted by Deneuve et al. in France (2010) with 78 cases, diagnostic accuracy of FNAB was reported as 94% with non-diagnostic results obtained in 10% of the cases. [13] In our study, FNAB-detected malignant and benign tumors were histopathologically confirmed in 87.5 and 93% of the cases, respectively. When non-diagnostic results were excluded, diagnostic value of FNAB was found to be 92 percent. FNAB and cytopathology results were in complete concordance in 42.1% of the cases. The reason for this low rate of concordance is especially related to requirement for tissue specimens to determine criteria of malignancy and inadequate amount of tissue retrieved for cytological examinations rather than misdiagnoses.
Despite scarce number of literature studies related to US-guided FNAB procedures, Feld et al. reported that use of US had facilitated application of FNAB procedure in heterogenous and non-palpable masses. [11] In our study, we analyzed tumors with solid, cystic and mixed components and adequacy of FNAB aspirate material and adequacy of FNAB was statistically significantly improved with concominant use of US (p=0.003). Rates of complete concordance between cytopathologic results with respect to diameters and locations of the parotid tumors included in our study were also analyzed. A significant correlation could not be found between diameter of the tumor and complete cytopathologic concordance (p=0.580). Complete cytopathologic concordance of FNAB was examined and any statistically significant difference was not found between the results of FNABs applied with or without US guidance (p=0.426).
Conclusion
Fine-needle aspiration biopsy is an easily applicable, reliable and cost-effective diagnostic tool. However, it can be performed under polyclinic conditions with or without USguidance, US increases adequacy of the material retrieved. Although preoperative FNAB does not establish specific diagnosis precisely with very high probability, it can especially discriminate between malignant and benign tumors in more than 90% of the cases. With these advantages FNAB is currently the best preoperative diagnostic tool in parotid tumors.
